EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.35
−2.67%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 14.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.68x
- Price / sales
- 4.24x
- Price / cash flow
- -0.48x
Enterprise value
- Enterprise value
- $7.3M
- EV / sales
- 5.62x
- EV / EBITDA
- -0.58x
- EV / EBIT
- -0.54x
- Market cap
- $5.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026